These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2282202)

  • 1. The additive effect of certain drugs on the cyclosporine A inhibition of human T-cell proliferation. Studies using theophyllamine, warfarin, verapamil and dipyridamol.
    Bruserud O
    APMIS; 1990 Dec; 98(12):1070-6. PubMed ID: 2282202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipyridamol inhibits activation of human T lymphocytes in vitro.
    Bruserud O
    Clin Immunol Immunopathol; 1987 Jan; 42(1):102-9. PubMed ID: 3098479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplantation; 1991 Apr; 51(4):851-7. PubMed ID: 2014542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ TCR alpha beta+ T-cell clones derived shortly after allogeneic bone marrow transplantation: theophyllamine and verapamil inhibit proliferation of functionally heterogeneous T-cells.
    Bruserud O; Hamann W; Patel S; Pawelec G
    Int J Immunopharmacol; 1992 Jul; 14(5):783-9. PubMed ID: 1387389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proliferative T-lymphocyte response to streptokinase.
    Bruserud O; Sollid L; Jørgensen PF
    J Clin Lab Immunol; 1986 Jun; 20(2):69-74. PubMed ID: 2942694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dipyridamole, theophyllamine and verapamil on spontaneous in vitro proliferation of myelogenous leukaemia cells.
    Bruserud O
    Acta Oncol; 1992; 31(1):53-8. PubMed ID: 1586506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects of calcium antagonists on cyclosporin A-induced inhibition of T-cell proliferation.
    Marx M; Weber M; Merkel F; Meyer zum Büschenfelde KH; Köhler H
    Nephrol Dial Transplant; 1990; 5(12):1038-44. PubMed ID: 2151399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of theophyllamine on T-lymphocyte activation in vitro.
    Bruserud O
    Clin Immunol Immunopathol; 1984 Jul; 32(1):111-8. PubMed ID: 6234116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of drugs used in anticoagulation therapy on T lymphocyte activation in vitro. II. Warfarin inhibits T lymphocyte activation.
    Bruserud O; Lundin K
    J Clin Lab Immunol; 1987 Aug; 23(4):169-73. PubMed ID: 2959784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional inhibitory effects of intravenous immunoglobulins in combination with cyclosporine A on human T lymphocyte alloproliferative response in vitro.
    Schanz U; Hügle T; Gmür J
    Transplantation; 1996 Jun; 61(12):1736-40. PubMed ID: 8685953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.
    Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH
    Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.
    Weir MR
    Am J Med; 1991 May; 90(5A):32S-36S. PubMed ID: 2039018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclosporin A on functions of specific murine T cell clones: inhibition of proliferation, lymphokine secretion and cytotoxicity.
    Weiss J; Schwinzer B; Kirchner H; Gemsa D; Resch K
    Immunobiology; 1986 Apr; 171(3):234-51. PubMed ID: 3086216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell.
    Granelli-Piperno A; Keane M; Steinman RM
    Transplantation; 1988 Aug; 46(2 Suppl):53S-60S. PubMed ID: 3136567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine polyclonal T-lymphocyte activation induced by phytohemmagglutinin; differential lymphokine requirements of two unusual activation pathways defined by resistance to blockade by barium and by cyclosporin A.
    Peçanha LM; Dos Reis GA
    Int J Immunopharmacol; 1989; 11(2):149-56. PubMed ID: 2649443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cyclic nucleotides on the proliferation of cultured human T-lymphocytes.
    Maca RD
    Immunopharmacology; 1984 Oct; 8(2):53-60. PubMed ID: 6096309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclosporins inhibit lymphocyte activation at more than one site.
    Gelfand EW; Cheung RK; Mills GB
    J Immunol; 1987 Feb; 138(4):1115-20. PubMed ID: 3492542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A.
    Foxwell BM; Simon J; Herrero JJ; Taylor D; Woerly G; Cantrell D; Ryffel B
    Immunology; 1990 Jan; 69(1):104-9. PubMed ID: 2312149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.